Hovedbudskap
-
Vitaminer og mineraler er essensielle næringsstoffer, og både for lavt og for høyt inntak har negative helseeffekter
-
Kvinner i fertil alder har økt risiko for jernmangel og kvinner som planlegger graviditet bør ta folattilskudd. Alle burde ta vitamin D-tilskudd i vinterhalvåret
-
Det finnes grupper i befolkningen som trenger kosttilskudd for å dekke behovet for vitaminer og mineraler, først og fremst alle som spiser lite eller ensidig
-
Den nyeste forskningen innen kosthold og helse tyder på at det største helsepotensialet ligger i kostens sammensetning, ikke i tilskuddene
- 1.
Stampfer MJ, Hennekens CH, Manson JE et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444 – 9.
- 2.
Rimm EB, Stampfer MJ, Ascherio A et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450 – 6.
- 3.
Virtamo J, Rapola JM, Ripatti S et al. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med 1998; 158: 668 – 75.
- 4.
Stephens NG, Parsons A, Schofield PM et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781 – 6.
- 5.
GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 1999; 354: 447 – 55.
- 6.
The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 154 – 60.
- 7.
Boaz M, Smetana S, Weinstein T et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000; 356: 1213 – 8.
- 8.
Collaborative Group of the Primary Prevention Project (PPP). Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 2001; 357: 89 – 95.
- 9.
Leppala JM, Virtamo J, Fogelholm R et al. Vitamin E and beta carotene supplementation in high risk for stroke: a subgroup analysis of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Arch Neurol 2000; 57: 1503 – 9.
- 10.
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 23 – 33.
- 11.
The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994; 330: 1029 – 35.
- 12.
Rapola JM, Virtamo J, Ripatti S et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infraction. Lancet 1997; 349: 1715 – 20.
- 13.
Meltzer HM, Meyer HE, Klepp K-I. Fra hypotese til kostråd – veier, snarveier og blindveier Tidsskr Nor Lægeforen 2004; 124: 1248 – 50.
- 14.
Sandström B, Aro A, Becker W et al. Nordiska näringsrekommendationer 1996. København: Nordisk ministerråd, 1996.
- 15.
Food and Nutrition Board, Institute of Medicine. Dietary reference intakes: a risk assessment model for establishing upper intake levels for nutrients. Washington D.C.: National Academy Press, 1998.
- 16.
WHO. Assessing human health risks of chemicals: derivation of guidance values for health-based exposure limits. Environmental Health Criteria 1994; volume 170.
- 17.
Reports of the Scientific Committee for Food. Nutrient and energy intakes for the European Community. Luxembourg: Commission of the European Communities, 1993.
- 18.
Trumbo P, Yates AA, Schlicker S, Poos M. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc 2001; 101: 294 – 301.
- 19.
Meltzer HM, Aro A, Andersen NL et al. Risk analysis applied to food fortification. Public Health Nutr 2003; 6: 281 – 90.
- 20.
Bendich A, Machlin LJ. The safety of oral intake of vitamin E: data from clinical studies from 1986 to 1991. I: Packer I, Fuchs J, red. Vitamin E in health and disease. New York: Marcel Decker, 1993: 411 – 6.
- 21.
Vatassery GT, Bauer T, Dysken M. High doses of vitamin E in the treatment of disorders of the central nervous system in the aged. Am J Clin Nutr 1999; 70: 793 – 801.
- 22.
Johansson L, Solvoll K. Norkost 1997. Landsomfattende kostholdsundersøkelse blant menn og kvinner i alderen 16 – 79 år. Rapport nr. 2/1999. Oslo: Statens råd for ernæring og fysisk aktivitet, 1999.
- 23.
Similä M, Fagt S, Vaask S et al. The NORBAGREEN 2002 study. TemaNord 2003: 556. København: Nordisk ministerråd, 2003.
- 24.
Norges offentlige utredninger. Alternativ medisin. NOU 1998: 21. Oslo, Statens forvaltningstjeneste, Seksjon statens trykning, 1998.
- 25.
Hemila H. Vitamin C intake and susceptibility to the common cold. Br J Nutr 1997; 77: 59 – 72.
- 26.
Ames BN, Elson-Schwab I, Silver EA. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): relevance to genetic disease and polymorphisms. Am J Clin Nutr 2002; 75: 616 – 58.